Product
Autologous VitD3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptides
1 clinical trial
3 indications
Indication
Multiple SclerosisIndication
Relapsing-RemittingIndication
Chronic ProgressiveClinical trial
Tolerance-Induction With Dendritic Cells Treated With Vitamin-D3 and Loaded With Myelin Peptides, in Multiple Sclerosis Patients (TOLERVIT-MS)Status: Recruiting, Estimated PCD: 2023-12-01